BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 28701182)

  • 1. Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells.
    Sharma A; Rani R
    Stem Cell Res Ther; 2017 Jul; 8(1):167. PubMed ID: 28701182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic Mice.
    Tsai PJ; Wang HS; Lin GJ; Chou SC; Chu TH; Chuan WT; Lu YJ; Weng ZC; Su CH; Hsieh PS; Sytwu HK; Lin CH; Chen TH; Shyu JF
    Cell Transplant; 2015; 24(8):1555-70. PubMed ID: 25198179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus.
    Domouky AM; Hegab AS; Al-Shahat A; Raafat N
    Int J Biochem Cell Biol; 2017 Jun; 87():77-85. PubMed ID: 28385600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of differentiated umbilical cord mesenchymal cells under kidney capsule for control of type I diabetes in rat.
    Moshrefi M; Yari N; Nabipour F; Bazrafshani MR; Nematollahi-mahani SN
    Tissue Cell; 2015 Aug; 47(4):395-405. PubMed ID: 26025422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia.
    Xin Y; Jiang X; Wang Y; Su X; Sun M; Zhang L; Tan Y; Wintergerst KA; Li Y; Li Y
    PLoS One; 2016; 11(1):e0145838. PubMed ID: 26756576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of insulin-producing cells differentiated from human periosteum-derived progenitor cells ameliorate hyperglycemia in diabetic mice.
    Dao LT; Park EY; Lim SM; Choi YS; Jung HS; Jun HS
    Transplantation; 2014 Nov; 98(10):1040-7. PubMed ID: 25208321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
    Yaochite JN; de Lima KW; Caliari-Oliveira C; Palma PV; Couri CE; Simões BP; Covas DT; Voltarelli JC; Oliveira MC; Donadi EA; Malmegrim KC
    Stem Cell Res Ther; 2016 Jan; 7():14. PubMed ID: 26781648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro.
    Sun Y; Chen L; Hou XG; Hou WK; Dong JJ; Sun L; Tang KX; Wang B; Song J; Li H; Wang KX
    Chin Med J (Engl); 2007 May; 120(9):771-6. PubMed ID: 17531117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells into Insulin-Producing Cells: Evidence for Further Maturation In Vivo.
    Gabr MM; Zakaria MM; Refaie AF; Khater SM; Ashamallah SA; Ismail AM; El-Halawani SM; Ghoneim MA
    Biomed Res Int; 2015; 2015():575837. PubMed ID: 26064925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice.
    Abdi R; Moore R; Sakai S; Donnelly CB; Mounayar M; Sackstein R
    Stem Cells; 2015 May; 33(5):1523-31. PubMed ID: 25641589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic insulin-producing cells differentiated from human embryonic stem cells correct hyperglycemia in SCID/NOD mice, an animal model of diabetes.
    Hua XF; Wang YW; Tang YX; Yu SQ; Jin SH; Meng XM; Li HF; Liu FJ; Sun Q; Wang HY; Li JY
    PLoS One; 2014; 9(7):e102198. PubMed ID: 25009980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat NOD mice.
    Wang HS; Shyu JF; Shen WS; Hsu HC; Chi TC; Chen CP; Huang SW; Shyr YM; Tang KT; Chen TH
    Cell Transplant; 2011; 20(3):455-66. PubMed ID: 20719086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of insulin-producing cells from C3H10T1/2 mesenchymal progenitor cells.
    Jian RL; Mao LB; Xu Y; Li XF; Wang FP; Luo XG; Zhou H; He HP; Wang N; Zhang TC
    Gene; 2015 May; 562(1):107-16. PubMed ID: 25724395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-producing cells from adult human bone marrow mesenchymal stem cells control streptozotocin-induced diabetes in nude mice.
    Gabr MM; Zakaria MM; Refaie AF; Ismail AM; Abou-El-Mahasen MA; Ashamallah SA; Khater SM; El-Halawani SM; Ibrahim RY; Uin GS; Kloc M; Calne RY; Ghoneim MA
    Cell Transplant; 2013; 22(1):133-45. PubMed ID: 22710060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exendin-4 enhances the differentiation of Wharton's jelly mesenchymal stem cells into insulin-producing cells through activation of various β-cell markers.
    Kassem DH; Kamal MM; El-Kholy Ael-L; El-Mesallamy HO
    Stem Cell Res Ther; 2016 Aug; 7(1):108. PubMed ID: 27515427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
    Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D
    Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion with Human Bone Marrow-derived Mesenchymal Stem Cells Improves β-cell Function in Patients and Non-obese Mice with Severe Diabetes.
    Li L; Hui H; Jia X; Zhang J; Liu Y; Xu Q; Zhu D
    Sci Rep; 2016 Dec; 6():37894. PubMed ID: 27905403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow stem cell-derived β-cells: New issue for diabetes cell therapy.
    Aglan HA; Kotob SE; Mahmoud NS; Kishta MS; Ahmed HH
    Tissue Cell; 2024 Feb; 86():102280. PubMed ID: 38029457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β engineered mesenchymal stem cells (TGF-β/MSCs) for treatment of Type 1 diabetes (T1D) mice model.
    Daneshmandi S; Karimi MH; Pourfathollah AA
    Int Immunopharmacol; 2017 Mar; 44():191-196. PubMed ID: 28110219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.
    Yaochite JN; Caliari-Oliveira C; de Souza LE; Neto LS; Palma PV; Covas DT; Malmegrim KC; Voltarelli JC; Donadi EA
    Stem Cell Res Ther; 2015 Mar; 6(1):31. PubMed ID: 25884215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.